13D/G large-stake feed
Since 01 Aug 2026. Review filer CIK, subject security, ownership %, and SEC evidence first.
Recent 13D/G signals
Start with holder, issuer/security, stake size, and SEC evidence.
Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.
Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.
Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.
Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.
Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.
Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.
Schedule 13D/G ownership events
Stake size, change direction, reporting filer, issuer, active/passive form type, and SEC evidence.
Visible reports
6
Fresh large-stake filings promoted above the legacy table.
13D/13G mix
3/3
Active-intent candidates versus passive large-stake disclosures.
Largest visible stake
75%
Highest class ownership surfaced in the preview cards.
Newest evidence
03 Aug 2026
Use recency before treating an old large-stake story as fresh.
Signal checks
active/control intent, item text, amendments
large passive holder disclosure
ownership percent and share change
issuer, filer history, insider activity, 13F context
SEC-verifiable Schedule 13D/G path
Open the Schedule 13D/G filing, then cross-check insider and Form 13F evidence.
FARALLON CAPITAL MANAGEMENT, L.L.C. filed Schedule 13G/A for BridgeBio Pharma, Inc. (BBIO). Reported class ownership: 5.5%. Open the SEC evidence before treating this as an activist or passive large-stake signal.
Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.
FARALLON CAPITAL MANAGEMENT, L.L.C. filed Schedule 13G/A for AGIOS PHARMACEUTICALS, INC. (AGIO). Reported class ownership: 9.9%. Open the SEC evidence before treating this as an activist or passive large-stake signal.
Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.
FARALLON CAPITAL MANAGEMENT, L.L.C. filed Schedule 13G/A for Crinetics Pharmaceuticals, Inc. (CRNX). Reported class ownership: 8.5%. Open the SEC evidence before treating this as an activist or passive large-stake signal.
Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.
FRANKLIN RESOURCES INC filed Schedule 13D/A for Franklin BSP Lending Fund. Reported class ownership: 47%. Ownership change: -3.1%. Share change: 0%. Open the SEC evidence before treating this as an activist or passive large-stake signal.
Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.
3i, LP filed Schedule 13D for Valion Bio, Inc. (VBIO). Reported class ownership: 9.9%. Ownership change: 0%. Share change: +45%. Open the SEC evidence before treating this as an activist or passive large-stake signal.
Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.
O.Y. Nofar Energy Ltd. filed Schedule 13D/A for Ellomay Capital Ltd. (ELLO). Reported class ownership: 75%. Ownership change: +29%. Share change: +64%. Open the SEC evidence before treating this as an activist or passive large-stake signal.
Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.
| Filed by | Symbol | Subject | Shares owned | Ownership % | Source |
|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT, L.L.C. CIK 0000909661 | BBIO | BridgeBio Pharma, Inc. | 10,743,063 | 5.5% | SEC filing |
| FARALLON CAPITAL MANAGEMENT, L.L.C. CIK 0000909661 | AGIO | AGIOS PHARMACEUTICALS, INC. | 5,917,400 | 9.9% | SEC filing |
| FARALLON CAPITAL MANAGEMENT, L.L.C. CIK 0000909661 | CRNX | Crinetics Pharmaceuticals, Inc. | 8,989,098 | 8.5% | SEC filing |
| FRANKLIN RESOURCES INC CIK 0000038777 | CUSIP 35243L403 | Franklin BSP Lending Fund | 75,000 | 47% | SEC filing |
| 3i, LP CIK 0001841619 | VBIO | Valion Bio, Inc. | 446,759 | 9.9% | SEC filing |
| O.Y. Nofar Energy Ltd. CIK 0002117505 | ELLO | Ellomay Capital Ltd. | 10,340,946 | 75% | SEC filing |